That has spread to other parts of the body or cannot be removed by surgery, and whose tumor is KRAS G12C positive, and who have received at least one prior treatment.1

RESOURCES

HOW CAN I LEARN MORE DURING MY NSCLC
TREATMENT JOURNEY?

It’s important to easily access the resources you may need during your NSCLC (non-small cell lung cancer) treatment. Download the guides below to keep them on hand for when you may need them.

LUMAKRAS™ Treatment Patient Resource

LUMAKRAS® Patient Treatment Resource

is now available in multiple languages

Download Document

SELECT LANGUAGE

DOWNLOAD LUMAKRAS®
PATIENT TREATMENT RESOURCE

Select document language to start downloading

English English Español Spanish Mandarin 普通话
LUMAKRAS™ Treatment Journal

Treatment Journal

Download Document

IN ENGLISH

KEY LUNG CANCER TERMS

Below are a list of common lung cancer terms and what they mean. You may find this information useful along your way.

  • Biomarker1

    Biomarkers are measurable characteristics that can provide information about your lung cancer. They can be measured in blood, other bodily fluids, or tissues.

  • Complete response1

    On an imaging scan, the tumor looks like it is completely gone as a result of treatment.

  • KRAS2

    KRAS is a protein that’s in all our bodies. It works like an on/off switch that tells cells when to grow and when to stop growing.

  • KRAS G12C3

    KRAS G12C is a mutation of the KRAS protein. This mutation causes the KRAS "on/off switch" to get stuck in the "on" position, leading to rapid and uncontrollable cell growth that can form tumors.

  • Mutation1

    A permanent change in the DNA sequence of a gene.

  • Partial response4

    The tumor has shrunk in size by at least 30%.

  • Stable disease1

    The tumor's size did not change much since a patient’s last imaging scan.

green-round-icon

Ask your doctor if LUMAKRAS®
is right for you

NEXT: SUPPORT ORGANIZATIONS